BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6394588)

  • 1. Membrane and genetic events in tumor promotion: studies with promoter resistant variants of JB6 cells.
    Colburn NH; Lerman MI; Srinivas L; Nakamura Y; Gindhart TD
    Princess Takamatsu Symp; 1983; 14():155-66. PubMed ID: 6394588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of specific membrane and genetic changes in the mechanism of tumour promotion. Studies with promoter-resistant variants.
    Colburn NH; Srinivas L; Hegamyer GA; Dion LD; Wendel EJ; Cohen M; Gindhart TD
    IARC Sci Publ; 1984; (56):205-15. PubMed ID: 6536596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: use of promoter-resistant variants for mechanism studies.
    Colburn NH; Wendel E; Srinivas L
    J Cell Biochem; 1982; 18(3):261-70. PubMed ID: 7068782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced trisialoganglioside synthesis in chemically but not mos-transformed mouse epidermal cells.
    Srinivas L; Colburn NH
    Cancer Res; 1984 Apr; 44(4):1510-4. PubMed ID: 6608408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genes that cooperate with tumor promoters in transformation.
    Colburn NH; Smith BM
    J Cell Biochem; 1987 Jun; 34(2):129-42. PubMed ID: 3597557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin induction is required for tumor promoter-induced transformation of preneoplastic mouse cells.
    Chang PL; Cao M; Hicks P
    Carcinogenesis; 2003 Nov; 24(11):1749-58. PubMed ID: 12919959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of 15 and 16 kDa nuclear proteins in promotion sensitive and promotion resistant mouse JB6 cells.
    Hirano K; Smith BM; Colburn NH
    Oncol Res; 1992; 4(1):17-21. PubMed ID: 1581616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition by tumor-promoting phorbol esters of procollagen synthesis in promotable JB6 mouse epidermal cells.
    Dion LD; Bear J; Bateman J; De Luca LM; Colburn NH
    J Natl Cancer Inst; 1982 Nov; 69(5):1147-54. PubMed ID: 6957659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfer by pro gene transfection of tumor promoter-sensitive phenotype to promotion-insensitive JB6 cells.
    Colburn NH; Smith BM; Wendel EJ; Dowjat WK; Shimada T
    Cancer Res; 1988 Mar; 48(5):1195-200. PubMed ID: 3342399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of mouse pro-1 and pro-2 transfectants for responses to tumor promoters and antipromoters.
    Colburn NH; Smith BM; Wendel EJ; Nakamura Y; Winterstein D
    Cancer Res; 1988 Nov; 48(21):6076-80. PubMed ID: 3139288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Four-day duration of tumor promoter exposure required to transform JB6 promotion-sensitive cells to anchorage independence.
    Dion LD; Gindhart TD; Colburn NH
    Cancer Res; 1988 Dec; 48(24 Pt 1):7126-31. PubMed ID: 3191489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
    Chang PL; Chambers AF
    J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genes and membrane signals involved in neoplastic transformation.
    Colburn NH
    Carcinog Compr Surv; 1985; 10():235-48. PubMed ID: 4064006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexose uptake as an indicator of JB6 mouse epidermal cell resistance to the mitogenic activity of TPA.
    Copley M; Gindhart T; Colburn N
    J Cell Physiol; 1983 Feb; 114(2):173-8. PubMed ID: 6822609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter-induced cellular responses closely correlated with the enhancement of cell transformation.
    Kakunaga T; Hirakawa T; Shimomura K; Sugimura T
    Princess Takamatsu Symp; 1983; 14():303-13. PubMed ID: 6097582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation.
    Watts RG; Huang C; Young MR; Li JJ; Dong Z; Pennie WD; Colburn NH
    Oncogene; 1998 Dec; 17(26):3493-8. PubMed ID: 10030673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells.
    Su L; Mukherjee AB; Mukherjee BB
    Oncogene; 1995 Jun; 10(11):2163-9. PubMed ID: 7784060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the antioxidative property of morusin in blocking phorbol ester-induced malignant transformation of JB6 P
    Cheng PS; Hu CC; Wang CJ; Lee YJ; Chung WC; Tseng TH
    Chem Biol Interact; 2017 Feb; 264():34-42. PubMed ID: 28108223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.